A DNA vaccine encoding mDEC-205-scFv linked with the HBsAg was constructed.
The immunogenicity can be enhanced by fusing the antigen to mDEC-205-scFv.
We demonstrated the therapeutic efficacy of the DNA vaccine in a HBV Tg mouse model.
The mDEC-205-scFv-fused DNA vaccine might be applied in therapeutic of HBV infection.